Loading...
XLON
NIOX
Market cap323mUSD
Jul 10, Last price  
57.80GBP
1D
0.70%
1Q
-0.34%
Jan 2017
-38.51%
IPO
-81.35%
Name

Niox Group PLC

Chart & Performance

D1W1MN
XLON:NIOX chart
P/E
34.70
P/S
4.99
EPS
0.02
Div Yield, %
1.74%
Shrs. gr., 5y
-0.77%
Rev. gr., 5y
9.24%
Revenues
49m
+16.49%
10,800,00015,918,12123,100,00028,543,50246,300,00062,632,31548,300,00061,514,87034,600,00045,836,37423,900,00032,670,08927,900,00037,715,22031,300,00037,854,22036,800,00046,846,40041,800,00048,692,108
Net income
7m
+89.16%
-49,900,000-73,547,618-137,300,000-169,654,673-99,100,000-134,057,505-117,100,000-149,138,537-48,300,000-63,985,459-33,500,000-45,792,8033,600,0004,866,48016,100,00016,100,00010,700,00010,700,0003,700,0006,998,865
CFO
16m
-8.15%
-55,800,000-77,821,929-56,700,000-69,196,370-57,600,000-76,565,638-40,600,000-51,071,352-25,100,000-32,721,342-23,900,000-32,670,0891,400,0001,892,5196,700,0008,223,92011,600,00015,530,59917,200,00015,797,439
Dividend
May 23, 20241 GBP/sh

Notes

No notes on this company yet
Write a private note on this company, for your eyes only
Add note

Profile

Niox Group Plc engages in the design, development, and commercialization of medical devices for the diagnosis and management of asthma. It offers NIOX VERO, a non-invasive point-of-care system that provides fractional exhaled nitric oxide (FeNO) measurements. The company was founded by Steven Harris and Charles Stuart Webb Swingland on May 19, 2006 and is headquartered in Oxford, the United Kingdom.
URL
https://investors.niox.com/
IPO date
Mar 13, 2014
Employees
Domiciled in
GB
Incorporated in
GB

Valuation

Title
GBP in thousands, except ratios and share amounts
FYFYFYFYFYFYFYFYFYFYFYFYFYFYFYFYFYFY
2025‑122024‑122023‑122023‑122022‑122022‑122021‑122021‑122020‑122020‑122019‑122019‑122018‑122018‑122017‑122017‑122016‑122016‑12
Income
Revenues
Cost of revenue
Unusual Expense (Income)
NOPBT
NOPBT Margin
Operating Taxes
Tax Rate
NOPAT
Net income
Dividends
Dividend yield
Proceeds from repurchase of equity
BB yield
Debt
Debt current
Long-term debt
Deferred revenue
Other long-term liabilities
Net debt
Cash flow
Cash from operating activities
CAPEX
Cash from investing activities
Cash from financing activities
FCF
Balance
Cash
Long term investments
Excess cash
Stockholders' equity
Invested Capital
ROIC
ROCE
EV
Common stock shares outstanding
Price
Market cap
EV
EBITDA
EV/EBITDA
Interest
Interest/NOPBT